Why it ranks
How the rank works10signal of 100 · rising 2
- team of 14Team size · YC's directory+6.1
- went through YCProgram · this site+4
A sum of public facts, not a judgement and not investment advice.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Not stated | EF2021 | |
| AI | Active | YCS20 | |
| AI | Active | YCW15 | |
| AI | Active | YCW20 | |
| AI | Active | YCS21 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCW23 | |
| AI | Active | YCS23 | |
| Other | Not stated | AWS GenAIInaugural cohort | |
| Other | Inactive | YCW20 | |
| Other | Active | YCW21 |
Also from W18 in AI
All of W18About Macromoltek
Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
- YC batch
- W18 · Winter 2018
- Status, per YC
- Active
- Category
- AI
- Team size
- 14
- Location
- Austin, TX, USA
- Checked
- 13h ago
YC tags: AI-powered Drug Discovery, Deep Learning, Therapeutics
Macromoltek: questions
Which YC batch was Macromoltek in?
Macromoltek was in Y Combinator's Winter 2018 batch (W18).
Is Macromoltek still active?
Y Combinator lists Macromoltek as active.
Where is Macromoltek based?
Macromoltek lists Austin, TX, USA as its location on YC's directory.